Home/Filings/4/0001209191-23-014276
4//SEC Filing

Davis Andrew 4

Accession 0001209191-23-014276

CIK 0001446847other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 6:17 PM ET

Size

7.8 KB

Accession

0001209191-23-014276

Insider Transaction Report

Form 4
Period: 2023-02-27
Davis Andrew
SVP, Chief Business Officer
Transactions
  • Sale

    Class A Common Stock

    2023-02-28$11.31/sh1,822$20,607151,396 total
  • Sale

    Class A Common Stock

    2023-02-27$11.41/sh1,751$19,979153,218 total
Footnotes (4)
  • [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The reporting person acquired 756 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2022.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001932525

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:17 PM ET
Size
7.8 KB